产品名称 | NebuSelect™ Recombinant Human TFPI, Avi-His-tag |
---|---|
目录号 | NBL-242040 |
别名 | TFPI; LACI; TFPI1; EPI; TFI; convertin; TFPI |
外观 | see COA |
分子量 | Asp29-Lys282 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P10646-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242040-100ug | 100ug | Inquire | Inquire | |
NBL-242040-1mg | 1mg | Inquire | Inquire | |
NBL-242040-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human TFPI, Avi-His-tag
Catalog#:
NBL-242040
Description:
NebuSelect™ Recombinant Human TFPI, Avi-His-tag(Cat#NBL-242040) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Asp29-Lys282.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
TFPI; LACI; TFPI1; EPI; TFI; convertin; TFPI
Target Information:
Oestrogens influence the pathophysiology and development of hormone-sensitive cancers, such as breast cancer. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation pathway and has recently been associated with breast cancer cell development.
Amino Acid Sequence:
Asp29-Lys282
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.